Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
RXRX is expected to report earnings to rise 20.24% to -40 cents per share on March 04
Q4'24
Est.
$-0.41
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.04
The last earnings report on November 07 showed earnings per share of -34 cents, missing the estimate of -33 cents. With 19.94M shares outstanding, the current market capitalization sits at 2.36B.